What is the price target for CBRE stock?
20 analysts have analysed CBRE and the average price target is 189.93 USD. This implies a price increase of 40.35% is expected in the next year compared to the current price of 135.325.
NYSE:CBRE • US12504L1098
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CBRE GROUP INC - A (CBRE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-23 | UBS | Upgrade | Neutral -> Buy |
| 2026-02-13 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-15 | Keefe, Bruyette & Woods | Upgrade | Market Perform -> Outperform |
| 2025-12-02 | Barclays | Initiate | Overweight |
| 2025-10-24 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-09 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-10-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-25 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-24 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-07-24 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-30 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-04-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-17 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-04-11 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.949B 3.64% | 35.767B 11.95% | 40.55B 13.37% | 46.44B 14.53% | 50.645B 9.05% | 55.116B 8.83% | 60.263B 9.34% | 64.201B 6.53% | 64.103B -0.15% | 68.185B 6.37% | 72.532B 6.38% | |
| EBITDA YoY % growth | 1.712B -11.71% | 2.2B 28.50% | 2.221B 0.95% | 3.852B 73.44% | 4.302B 11.68% | 4.757B 10.58% | 5.106B 7.34% | 5.408B 5.91% | 5.415B 0.13% | 5.775B 6.65% | 6.143B 6.37% | |
| EBIT YoY % growth | 1.09B -17.80% | 1.526B 40.00% | 1.293B -15.27% | 3.159B 144.32% | 3.496B 10.67% | 3.892B 11.33% | 3.54B -9.04% | 3.658B 3.33% | 3.963B 8.34% | 4.29B 8.25% | 4.631B 7.95% | |
| Operating Margin | 3.41% | 4.27% | 3.19% | 6.80% | 6.90% | 7.06% | 5.87% | 5.70% | 6.18% | 6.29% | 6.38% | |
| EPS YoY % growth | 3.84 -32.39% | 5.11 33.07% | 6.39 25.05% | 7.58 18.69% | 8.81 16.10% | 9.98 13.30% | 12.19 22.18% | 13.92 14.23% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.14 32.81% | 1.51 26.75% | 1.88 16.97% | 3.07 12.63% | 1.36 19.26% | 1.78 17.73% | 2.10 11.25% | 3.53 14.83% | 1.45 6.33% | 1.88 5.74% | 2.34 11.83% |
| Revenue Q2Q % growth | 10.477B 17.59% | 11.301B 15.86% | 10.141B -1.14% | 12.918B 11.08% | 10.77B 2.80% | 11.674B 3.30% | 12.23B 20.60% | 13.838B 7.12% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 669.01M 33.53% | 817.17M 0.02% | 928.93M -18.30% | 1.381B 20.61% | 726.24M 8.55% | 886.02M 8.43% | 1.009B 8.62% | 1.517B 9.85% | 796.72M 9.70% | 939.73M 6.06% | 1.132B 12.19% |
| EBIT Q2Q % growth | 491.83M 78.20% | 624.61M 75.95% | 754.44M 69.54% | 1.003B 362.21% | 557.94M 13.44% | 737.46M 18.07% | 819.06M 8.57% | 1.133B 12.96% | N/A | N/A | N/A |
All data in USD
20 analysts have analysed CBRE and the average price target is 189.93 USD. This implies a price increase of 40.35% is expected in the next year compared to the current price of 135.325.
CBRE GROUP INC - A (CBRE) will report earnings on 2026-04-22.
The consensus EPS estimate for the next earnings of CBRE GROUP INC - A (CBRE) is 1.14 USD and the consensus revenue estimate is 10.48B USD.
The consensus rating for CBRE GROUP INC - A (CBRE) is 83 / 100 . This indicates that analysts generally have a positive outlook on the stock.